Valuation : Paion AG

Market Cap 144K 167K 136K 124K 231K 15.93M 232K 1.61M 622K 8.12M 629K 615K 25.72M P/E 2021
-3.89x
P/E 2022 -53x
Enterprise Value 9.87M 11.47M 9.29M 8.47M 15.84M 1.09B 15.9M 110M 42.56M 556M 43.06M 42.12M 1.76B EV / Sales 2021
14.1x
EV / Sales 2022 1.22x
Free-Float
100%
Yield 2021 *
-
Yield 2022 -
1 day+4.35%
1 week+4.35%
Current month+4.35%
1 month+9.09%
3 months-11.11%
6 months-27.27%
Current year+263.64%
1 week 0.05
Extreme 0.046
0.05
1 month 0.04
Extreme 0.044
0.05
Current year 0.01
Extreme 0.012
0.23
1 year 0.01
Extreme 0.009
0.23
3 years 0
Extreme 0.0001
5.01
5 years 0
Extreme 0.0001
18.94
10 years 0
Extreme 0.0001
36.78
Manager TitleAgeSince
Chief Executive Officer 62 31/08/2023
Director of Finance/CFO - 31/05/2022
Director TitleAgeSince
Director/Board Member 65 30/09/2012
Director/Board Member 75 31/05/2017
Director/Board Member - 21/05/2019
Date Insider Type Main position Quantity % Market Cap. Importance
27/12/22 Buy

Director

1,121 0.0016%
12/01/21 Buy

Chief Executive Officer

8,500 0.0127%
08/06/20 Buy

Chief Executive Officer

13,158 0.0202%
Change 5-day change 1-year change 3-year change Capi.($)
+4.35%+4.35%+433.33%-99.07% 382K
-3.24%-7.78%-5.35%+11.20% 48.01B
+0.17%-0.74%+407.28%+546.58% 44.44B
-0.86%-2.60%+35.51%+20.35% 42.67B
-0.14%-2.98%-0.04%+82.21% 39.96B
0.00%-1.72%+13.42%+42.33% 32.75B
-3.44%-2.43% - - 17.74B
-0.78%-1.13%+20.74%+116.26% 16.49B
-0.37%-2.53%+10.91%+30.93% 14.38B
-0.86%-4.60%+76.86%+39.36% 13.4B
Average -0.52%-1.51%+110.30%+87.79% 26.98B
Weighted average by Cap. -1.04%-2.20%+84.59%+131.91%

Financials

2021 2022
Net sales 7.13M 8.28M 6.71M 6.12M 11.44M 788M 11.49M 79.55M 30.75M 402M 31.11M 30.43M 1.27B 33.25M 38.64M 31.31M 28.52M 53.37M 3.68B 53.58M 371M 143M 1.87B 145M 142M 5.93B
Net income -21.79M -25.32M -20.51M -18.69M -34.97M -2.41B -35.11M -243M -93.96M -1.23B -95.07M -93M -3.89B -579K -673K -545K -497K -929K -64.03M -933K -6.46M -2.5M -32.62M -2.53M -2.47M -103M
Net Debt 13.77M 16M 12.96M 11.81M 22.1M 1.52B 22.19M 154M 59.39M 776M 60.08M 58.78M 2.46B 9.72M 11.3M 9.16M 8.34M 15.61M 1.08B 15.67M 109M 41.94M 548M 42.43M 41.51M 1.74B
Logo Paion AG
Paion AG is a Germany-based biopharmaceutical company. The Company's main product is remimazolam, an intravenous ultra-short-acting benzodiazepine sedative and anesthetic. In the human body, remimazolam is metabolized to an inactive metabolite by tissue esterase and not metabolized by cytochrome-dependent hepatic pathways. In addition to that, remimazolam, which is in Phase III clinical development, can be reversed with flumazenil to terminate sedation and anesthesia, if necessary. The product can be used for general anesthesia in Europe and procedural sedation in the United States. The Company operates sites in Aachen, Germany, Cambridge, the United Kingdom, and New Jersey, the United States.
Employees
64
Date Price Change Volume
09/09/26 €0.0480 +4.35% 0
08/09/26 €0.0460 0.00% 0
07/09/26 €0.0460 0.00% 0
04/09/26 €0.0460 0.00% 0
03/09/26 €0.0460 0.00% 2,218
  1. Stock Market
  2. Stocks
  3. PA8K Stock